amygdalin has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Hu, Y; Mou, X; Wang, H; Xie, Z | 1 |
| Dorfman, LM; Heikkila, RE; Meckstroth, WK | 1 |
| Cabbat, FS; Heikkila, RE | 1 |
3 other study(ies) available for amygdalin and Alloxan Diabetes
| Article | Year |
|---|---|
Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats.
Topics: Amygdalin; Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial-Mesenchymal Transition; Female; Fibrosis; Glucose; Inflammation; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction; Streptozocin; Transforming Growth Factor beta1 | 2021 |
Reactivity of the hydroxyl radical with amygdalin in aqueous solution.
Topics: Amygdalin; Animals; Chemical Phenomena; Chemistry; Diabetes Mellitus, Experimental; Hydroxides; Kinetics; Solutions; Water | 1980 |
The prevention of alloxan-induced diabetes by amygdalin.
Topics: Alloxan; Amygdalin; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Male; Mice | 1980 |